Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$27,000.00

Investigating the Role of Calpain in Pulmonary Arterial Hypertension

FY 2024-25

Summary
This project will investigate how the protein calpain worsens pulmonary arterial hypertension (PAH) and could direct future research for treatment.Pulmonary arteries carry blood from the heart to the lungs, and usually the pressure in these arteries is quite low. However, PAH occurs when pressure in the pulmonary arteries becomes dangerously elevated. This higher pressure puts stress on the heart and lungs, leading to severe consequences such as the inability to perform daily activities, shortness of breath, fatigue, heart failure, and even death. In PAH, cells in the pulmonary arteries rapidly divide which narrows the arteries and restricts blood flow. Additionally, the pulmonary arteries lose their ability to stretch to accommodate higher blood pressures. The causes of this uncontrolled cell division are unknown, yet further understanding of the causes could lead to new PAH treatments. The protein calpain may play a pivotal role in the cell division process. Calpain breaks down a protein called spectrin, an essential part of the cell skeleton. When spectrin breaks down, it can trigger cell division. Studies have shown that calpain is responsible for causing uncontrolled cell division elsewhere in the body. Therefore, it merits investigation for its role in PAH development.This project has three goals: (1) to determine how calpain and spectrin interact to affect the arteries ability to respond to stretch, (2) to understand how spectrin breakdown causes rapid division of artery cells, and (3) to assess whether calpain inhibition can slow PAH progression in animal models. This research could lead to a better understanding of the causes of PAH and result in better outcomes for patients.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
530293
Name
McMahon Adam M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the Role of Calpain in Pulmonary Arterial Hypertension
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Anesthesiology; Calpain; Cardiology; Pulmonary Hypertension; Spectrin
Abstract
This project will investigate how the protein calpain worsens pulmonary arterial hypertension (PAH) and could direct future research for treatment.Pulmonary arteries carry blood from the heart to the lungs, and usually the pressure in these arteries is quite low. However, PAH occurs when pressure in the pulmonary arteries becomes dangerously elevated. This higher pressure puts stress on the heart and lungs, leading to severe consequences such as the inability to perform daily activities, shortness of breath, fatigue, heart failure, and even death. In PAH, cells in the pulmonary arteries rapidly divide which narrows the arteries and restricts blood flow. Additionally, the pulmonary arteries lose their ability to stretch to accommodate higher blood pressures. The causes of this uncontrolled cell division are unknown, yet further understanding of the causes could lead to new PAH treatments. The protein calpain may play a pivotal role in the cell division process. Calpain breaks down a protein called spectrin, an essential part of the cell skeleton. When spectrin breaks down, it can trigger cell division. Studies have shown that calpain is responsible for causing uncontrolled cell division elsewhere in the body. Therefore, it merits investigation for its role in PAH development.This project has three goals: (1) to determine how calpain and spectrin interact to affect the arteries ability to respond to stretch, (2) to understand how spectrin breakdown causes rapid division of artery cells, and (3) to assess whether calpain inhibition can slow PAH progression in animal models. This research could lead to a better understanding of the causes of PAH and result in better outcomes for patients.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
McMahon, Adam M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~